Effect of inhaled racemic and (R)-albuterol on airway vascular smooth muscle tone in healthy and asthmatic subjects

A. Pereira, Eliana Mendes, Tanira Ferreira, Adam Wanner

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Although the relative effect of racemic and (R)-albuterol on airway smooth muscle tone have been investigated in patients with airflow obstruction, the comparative effectiveness of these drugs in relaxing airway vascular smooth muscle is unknown. Therefore, we determined the actions of inhaled racemic and (R)-albuterol on airway mucosal blood flow (Q̇aw) normalized for anatomic dead space as an index of airway vascular smooth muscle tone in 11 healthy subjects and 10 subjects with mild asthma. We also monitored the forced expiratory volume in 1 second. (FEV1) as an index of airway smooth muscle tone. Mean ± SE baseline Q̇aw was 43.1 ± 1.5 μl.min-1.ml-1 in healthy subjects and 53.4 ± 2. 1 μl.min-1.ml-1 in asthmatic subjects (p < 0.01). The corresponding values for FEV1 were 95.6 ± 1.4 and 86.8 ± 2.5% respectively, of predicted (p = 0.01.). Racemic and (R)-albuterol caused a transient, dose-dependent increase of Q̇aw in healthy, but not in asthmatic subjects; the responses were not different between the two drugs. The FEV1 tended to increase more in asthmatics than in healthy subjects, again without a difference between the two drugs. These results show that racemic and (R)-albuterol have comparable effects on airway vascular smooth muscle and suggest that the blunted airway vascular smooth muscle response to albuterol in asthmatics is not related to (S)-albuterol.

Original languageEnglish
Pages (from-to)201-211
Number of pages11
JournalLung
Volume181
Issue number4
DOIs
StatePublished - Oct 7 2003

Fingerprint

Albuterol
Vascular Smooth Muscle
Healthy Volunteers
Smooth Muscle
Pharmaceutical Preparations
Forced Expiratory Volume
Asthma

Keywords

  • Airway blood flow
  • Asthma
  • Beta-2 agonists

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Physiology

Cite this

Effect of inhaled racemic and (R)-albuterol on airway vascular smooth muscle tone in healthy and asthmatic subjects. / Pereira, A.; Mendes, Eliana; Ferreira, Tanira; Wanner, Adam.

In: Lung, Vol. 181, No. 4, 07.10.2003, p. 201-211.

Research output: Contribution to journalArticle

@article{2350c97924424ebe9ed8543bdcdee08a,
title = "Effect of inhaled racemic and (R)-albuterol on airway vascular smooth muscle tone in healthy and asthmatic subjects",
abstract = "Although the relative effect of racemic and (R)-albuterol on airway smooth muscle tone have been investigated in patients with airflow obstruction, the comparative effectiveness of these drugs in relaxing airway vascular smooth muscle is unknown. Therefore, we determined the actions of inhaled racemic and (R)-albuterol on airway mucosal blood flow (Q̇aw) normalized for anatomic dead space as an index of airway vascular smooth muscle tone in 11 healthy subjects and 10 subjects with mild asthma. We also monitored the forced expiratory volume in 1 second. (FEV1) as an index of airway smooth muscle tone. Mean ± SE baseline Q̇aw was 43.1 ± 1.5 μl.min-1.ml-1 in healthy subjects and 53.4 ± 2. 1 μl.min-1.ml-1 in asthmatic subjects (p < 0.01). The corresponding values for FEV1 were 95.6 ± 1.4 and 86.8 ± 2.5{\%} respectively, of predicted (p = 0.01.). Racemic and (R)-albuterol caused a transient, dose-dependent increase of Q̇aw in healthy, but not in asthmatic subjects; the responses were not different between the two drugs. The FEV1 tended to increase more in asthmatics than in healthy subjects, again without a difference between the two drugs. These results show that racemic and (R)-albuterol have comparable effects on airway vascular smooth muscle and suggest that the blunted airway vascular smooth muscle response to albuterol in asthmatics is not related to (S)-albuterol.",
keywords = "Airway blood flow, Asthma, Beta-2 agonists",
author = "A. Pereira and Eliana Mendes and Tanira Ferreira and Adam Wanner",
year = "2003",
month = "10",
day = "7",
doi = "10.1007/s00408-003-1022-1",
language = "English",
volume = "181",
pages = "201--211",
journal = "Lung",
issn = "0341-2040",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Effect of inhaled racemic and (R)-albuterol on airway vascular smooth muscle tone in healthy and asthmatic subjects

AU - Pereira, A.

AU - Mendes, Eliana

AU - Ferreira, Tanira

AU - Wanner, Adam

PY - 2003/10/7

Y1 - 2003/10/7

N2 - Although the relative effect of racemic and (R)-albuterol on airway smooth muscle tone have been investigated in patients with airflow obstruction, the comparative effectiveness of these drugs in relaxing airway vascular smooth muscle is unknown. Therefore, we determined the actions of inhaled racemic and (R)-albuterol on airway mucosal blood flow (Q̇aw) normalized for anatomic dead space as an index of airway vascular smooth muscle tone in 11 healthy subjects and 10 subjects with mild asthma. We also monitored the forced expiratory volume in 1 second. (FEV1) as an index of airway smooth muscle tone. Mean ± SE baseline Q̇aw was 43.1 ± 1.5 μl.min-1.ml-1 in healthy subjects and 53.4 ± 2. 1 μl.min-1.ml-1 in asthmatic subjects (p < 0.01). The corresponding values for FEV1 were 95.6 ± 1.4 and 86.8 ± 2.5% respectively, of predicted (p = 0.01.). Racemic and (R)-albuterol caused a transient, dose-dependent increase of Q̇aw in healthy, but not in asthmatic subjects; the responses were not different between the two drugs. The FEV1 tended to increase more in asthmatics than in healthy subjects, again without a difference between the two drugs. These results show that racemic and (R)-albuterol have comparable effects on airway vascular smooth muscle and suggest that the blunted airway vascular smooth muscle response to albuterol in asthmatics is not related to (S)-albuterol.

AB - Although the relative effect of racemic and (R)-albuterol on airway smooth muscle tone have been investigated in patients with airflow obstruction, the comparative effectiveness of these drugs in relaxing airway vascular smooth muscle is unknown. Therefore, we determined the actions of inhaled racemic and (R)-albuterol on airway mucosal blood flow (Q̇aw) normalized for anatomic dead space as an index of airway vascular smooth muscle tone in 11 healthy subjects and 10 subjects with mild asthma. We also monitored the forced expiratory volume in 1 second. (FEV1) as an index of airway smooth muscle tone. Mean ± SE baseline Q̇aw was 43.1 ± 1.5 μl.min-1.ml-1 in healthy subjects and 53.4 ± 2. 1 μl.min-1.ml-1 in asthmatic subjects (p < 0.01). The corresponding values for FEV1 were 95.6 ± 1.4 and 86.8 ± 2.5% respectively, of predicted (p = 0.01.). Racemic and (R)-albuterol caused a transient, dose-dependent increase of Q̇aw in healthy, but not in asthmatic subjects; the responses were not different between the two drugs. The FEV1 tended to increase more in asthmatics than in healthy subjects, again without a difference between the two drugs. These results show that racemic and (R)-albuterol have comparable effects on airway vascular smooth muscle and suggest that the blunted airway vascular smooth muscle response to albuterol in asthmatics is not related to (S)-albuterol.

KW - Airway blood flow

KW - Asthma

KW - Beta-2 agonists

UR - http://www.scopus.com/inward/record.url?scp=0141506001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141506001&partnerID=8YFLogxK

U2 - 10.1007/s00408-003-1022-1

DO - 10.1007/s00408-003-1022-1

M3 - Article

C2 - 14692560

AN - SCOPUS:0141506001

VL - 181

SP - 201

EP - 211

JO - Lung

JF - Lung

SN - 0341-2040

IS - 4

ER -